Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jun 24, 2021 3:41pm
57 Views
Post# 33445403

RE:RE:RE:RE:Production jobs available at Laval plant!

RE:RE:RE:RE:Production jobs available at Laval plant!

You are an incredibly deceptive guy. The numbers are right out of the presentation slides. When they get rid of the plasma division, they go to $5M per month without financing costs of a few $M a quarter.

the bigger question is what are they working on? It will take them months and months to decide on next thing in the clinic and then have to set up trial with fda and then they run out of money. Management still making preposterous salaries for a $100M market cap company based apparently on lies of former managers or lies of current owners by devaluation of 4050. No explanation whatsoever on IPF failure... Thomson pulling a fast one? Or dr Moran lied? I don't think Moran lied!


realstocky wrote: stockb go listen to the cc, they cut expenses and its now 5M$, ...they cashed 17M$ u.s., 3M + 5M ($u.s.) ...and the voucher will shortly bring in 70M$ ($u.s.), money is not a problem.

tommyjones1 wrote:

someone said this was a risky stock, i would qualify it more volatile than risky, no doubt this will trade a lot higher in 2-3 months once the  voucher money ( around 70M$u.s. ) is cashed.... i also think we have other news coming in. Market doesnt like uncertainty, this will be fixed soon.

 

 

Newcamo wrote: Wtf!!! i wonder what they'll produce plitheone!!! what could it be? Doritos? Fritos? Skittles? RiplaZYM?   We'll  know soon buddy, hang in there.

 

realstocky wrote:

u might be right on that one plitheone, something is going! Good luck.

https://liminalbiosciences.com/careers/laval/
 


 

 




<< Previous
Bullboard Posts
Next >>